The majority of Directors of Investor Relations at Dechra Pharmaceuticals believe they're compensated fairly. The vast majority (75%) of Directors of Investor Relations at Dechra Pharmaceuticals are satisfied with their benefits. See more compensation ratings at Dechra Pharmaceuticals